RIGHT TO TRY 2.0
RIGHT TO TRY 2.0 (2025-2Q) The idea behind Right-To-Try is that “terminally ill patients who have exhausted their government-approved options” should have the freedom to access treatments that may help them.(1) The idea originated with the Goldwater Institute of Arizona, a member of the State Policy Network (SPN), a market-based group that includes the […]